Chromium Hba1c Meta-Analysis Evidence Table

Structured evidence table for Chromium Hba1c Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Chromium Hba1c Meta-Analysis1 1 2 Table 1 Aspect Details References Metabolic syndrome is a cluster of conditions that increase the risk of heart disease, stroke, and diabetes.1Babakr Abdullatif Taha (2026)Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes
Chromium Hba1c Meta-Analysis1 [] Common risk factors include obesity (BMI ≥ 25 kg/m), increased waist circumference (>102 cm for men, >88 cm for women), hypertension, smoking, hyperlipidemia, age > 40 years, and a history of gestational diabetes.1Babakr Abdullatif Taha (2026)Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes
Chromium Hba1c Meta-Analysis5 [] Metabolic syndrome increases the risk of cardiovascular diseases, kidney disease, eye problems, neuropathy, and diabetes-related complications such as foot ulcers and amputations.1Babakr Abdullatif Taha (2026)Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes
Chromium Hba1c Meta-AnalysisIt includes central obesity, insulin resistance, hypertension, and dyslipidemia.1Babakr Abdullatif Taha (2026)Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes
Chromium Hba1c Meta-AnalysisType 2 diabetes (T2D) is the most common type of diabetes worldwide, accounting for over 90% of all cases.1Mangal DK (2025)A systematic review and meta-analysis to assess the effect of hidden hunger on glycaemic control in patients with type 2 diabetes.
Chromium Hba1c Meta-AnalysisMicronutrient deficiencies (hidden hunger) are implicated in glycaemic control among T2D patients.1Mangal DK (2025)A systematic review and meta-analysis to assess the effect of hidden hunger on glycaemic control in patients with type 2 diabetes.
topicChromium Hba1c Meta-Analysis
claim1 1 2 Table 1 Aspect Details References Metabolic syndrome is a cluster of conditions that increase the risk of heart disease, stroke, and diabetes.
evidence level1
citationBabakr Abdullatif Taha (2026)
sourceChromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes
topicChromium Hba1c Meta-Analysis
claim1 [] Common risk factors include obesity (BMI ≥ 25 kg/m), increased waist circumference (>102 cm for men, >88 cm for women), hypertension, smoking, hyperlipidemia, age > 40 years, and a history of gestational diabetes.
evidence level1
citationBabakr Abdullatif Taha (2026)
sourceChromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes
topicChromium Hba1c Meta-Analysis
claim5 [] Metabolic syndrome increases the risk of cardiovascular diseases, kidney disease, eye problems, neuropathy, and diabetes-related complications such as foot ulcers and amputations.
evidence level1
citationBabakr Abdullatif Taha (2026)
sourceChromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes
topicChromium Hba1c Meta-Analysis
claimIt includes central obesity, insulin resistance, hypertension, and dyslipidemia.
evidence level1
citationBabakr Abdullatif Taha (2026)
sourceChromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes
topicChromium Hba1c Meta-Analysis
claimType 2 diabetes (T2D) is the most common type of diabetes worldwide, accounting for over 90% of all cases.
evidence level1
citationMangal DK (2025)
sourceA systematic review and meta-analysis to assess the effect of hidden hunger on glycaemic control in patients with type 2 diabetes.
topicChromium Hba1c Meta-Analysis
claimMicronutrient deficiencies (hidden hunger) are implicated in glycaemic control among T2D patients.
evidence level1
citationMangal DK (2025)
sourceA systematic review and meta-analysis to assess the effect of hidden hunger on glycaemic control in patients with type 2 diabetes.

Source documents

  1. Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes
  2. A systematic review and meta-analysis to assess the effect of hidden hunger on glycaemic control in patients with type 2 diabetes.